Angiogenesis regulation by TGFβ signalling: Clues from an inherited vascular disease

Biochemical Society Transactions

Volumn 39, Issue 6, 2011, Pages 1659-1666

  Mahmoud, Marwa ^a   Upton, Paul D ^b   Arthur, Helen M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Activin receptor like kinase 1 (ACVRL1); Angiogenesis; Endoglin; Hereditary haemorrhagic telangiectasia (HHT); Transforming growth factor (TGF ); Vascular disease

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; BONE MORPHOGENETIC PROTEIN 9; ENDOGLIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN C JUN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ANGIOGENESIS; ARTERIOVENOUS MALFORMATION; CONFERENCE PAPER; ENDOTHELIUM CELL; GENE EXPRESSION; GENE MUTATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; RENDU OSLER WEBER DISEASE; SIGNAL TRANSDUCTION; VASCULAR DISEASE;

AMINO ACID SEQUENCE; ANIMALS; BLOOD VESSELS; HUMANS; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; VASCULAR DISEASES;

MUS;

EID: 81855169461     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20110664     Document Type: Conference Paper

References (69)

1. Shovlin, C.L. (2010) Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev. 24, 203-219
2. Braverman, I.M., Keh, A. and Jacobson, B.S. (1990) Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J. Invest. Dermatol. 95, 422-427 (Pubitemid 20331987)
3. ten Dijke, P. and Arthur, H.M. (2007) Extracellular control of TGFβ signalling in vascular development and disease. Nat. Rev. 8, 857-869
4. McAllister, K.A., Grogg, K.M., Johnson, D.W., Gallione, C.J., Baldwin, M.A., Jackson, C.E., Helmbold, E.A., Markel, D.S., McKinnon, W.C., Murrell, J. et al. (1994) Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat. Genet. 8, 345-351
5. Johnson, D.W., Berg, J.N., Baldwin, M.A., Gallione, C.J., Marodel, I., Yoon, S.J., Stenzel, T.T., Speer, M., Pericak-Vance, M.A., Diamond, A. et al. (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat. Genet. 13, 189-195
6. Gallione, C.J., Repetto, G.M., Legius, E., Rustgi, A.K., Schelley, S.L., Tejpar, S., Mitchell, G., Drouin, E., Westermann, C.J. and Marchuk, D.A. (2004) A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363, 852-859 (Pubitemid 38368834)
7. Gougos, A. and Letarte, M. (1990) Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J. Biol. Chem. 265, 8361-8364
8. Llorca, O., Trujillo, A., Blanco, F.J. and Bernabeu, C. (2007) Structural model of human endoglin, a transmembrane receptor responsible for hereditary hemorrhagic telangiectasia. J. Mol. Biol. 365, 694-705 (Pubitemid 44960353)
9. Lin, S.J., Hu, Y., Zhu, J., Woodruff, T.K. and Jardetzky, T.S. (2011) Structure of betaglycan zona pellucida (ZP)-C domain provides insights into ZP-mediated protein polymerization and TGF-β binding. Proc. Natl. Acad. Sci. U.S.A. 108, 5232-5236
10. Lee, N.Y., Ray, B., How, T. and Blobe, G.C. (2008) Endoglin promotes transforming growth factor β-mediated Smad 1/5/8 signaling and inhibits endothelial cell migration through its association with GIPC. J. Biol. Chem. 283, 32527-32533
11. Lastres, P., Martin-Perez, J., Langa, C. and Bernabeu, C. (1994) Phosphorylation of the human-transforming-growth-factor-β-binding protein endoglin. Biochem. J. 301, 765-768
12. Koleva, R.I., Conley, B.A., Romero, D., Riley, K.S., Marto, J.A., Lux, A. and Vary, C.P. (2006) Endoglin structure and function: determinants of endoglin phosphorylation by transforming growth factor-β receptors. J. Biol. Chem. 281, 25110-25123 (Pubitemid 44401898)
13. Ray, B.N., Lee, N.Y., How, T. and Blobe, G.C. (2010) ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration. Carcinogenesis 31, 435-441
14. Conley, B.A., Koleva, R., Smith, J.D., Kacer, D., Zhang, D., Bernabeu, C. and Vary, C.P. (2004) Endoglin controls cell migration and composition of focal adhesions: function of the cytosolic domain. J. Biol. Chem. 279, 27440-27449 (Pubitemid 38812583)
15. Sanz-Rodriguez, F., Guerrero-Esteo, M., Botella, L.M., Banville, D., Vary, C.P. and Bernabeu, C. (2004) Endoglin regulates cytoskeletal organization through binding to ZRP-1, a member of the Lim family of proteins. J. Biol. Chem. 279, 32858-32868 (Pubitemid 39014746)
16. Meng, Q., Lux, A., Holloschi, A., Li, J., Hughes, J.M., Foerg, T., McCarthy, J.E., Heagerty, A.M., Kioschis, P., Hafner, M. and Garland, J.M. (2006) Identification of Tctex2β, a novel dynein light chain family member that interacts with different transforming growth factor-β receptors. J. Biol. Chem. 281, 37069-37080 (Pubitemid 46042177)
17. Lee, N.Y. and Blobe, G.C. (2007) The interaction of endoglin with β-arrestin2 regulates transforming growth factor-β-mediated ERK activation and migration in endothelial cells. J. Biol. Chem. 282, 21507-21517 (Pubitemid 47099970)
18. Bellon, T., Corbi, A., Lastres, P., Cales, C., Cebrian, M., Vera, S., Cheifetz, S., Massague, J., Letarte, M. and Bernabeu, C. (1993) Identification and expression of two forms of the human transforming growth factor-β-binding protein endoglin with distinct cytoplasmic regions. Eur. J. Immunol. 23, 2340-2345 (Pubitemid 23265903)
19. Perez-Gomez, E., Eleno, N., Lopez-Novoa, J.M., Ramirez, J.R., Velasco, B., Letarte, M., Bernabeu, C. and Quintanilla, M. (2005) Characterization of murine S-endoglin isoform and its effects on tumor development. Oncogene 24, 4450-4461 (Pubitemid 40961768)
20. Li, C., Hampson, I.N., Hampson, L., Kumar, P., Bernabeu, C. and Kumar, S. (2000) CD105 antagonizes the inhibitory signaling of transforming growth factor β1 on human vascular endothelial cells. FASEB J. 14, 55-64 (Pubitemid 30051523)
21. Blanco, F.J., Grande, M.T., Langa, C., Oujo, B., Velasco, S., Rodriguez-Barbero, A., Perez-Gomez, E., Quintanilla, M., Lopez-Novoa, J.M. and Bernabeu, C. (2008) S-endoglin expression is induced in senescent endothelial cells and contributes to vascular pathology. Circ. Res. 103, 1383-1392
22. Blanco, F.J. and Bernabeu, C. (2011) Alternative splicing factor or splicing factor-2 plays a key role in intron retention of the endoglin gene during endothelial senescence. Aging Cell 10, 896-907
23. Venkatesha, S., Toporsian, M., Lam, C., Hanai, J., Mammoto, T., Kim, Y.M., Bdolah, Y., Lim, K.H., Yuan, H.T., Libermann, T.A. et al. (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med. 12, 642-649 (Pubitemid 43865232)
24. Hawinkels, L.J., Kuiper, P., Wiercinska, E., Verspaget, H.W., Liu, Z., Pardali, E., Sier, C.F. and ten Dijke, P. (2010) Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. Cancer Res. 70, 4141-4150
25. de Caestecker, M. (2004) The transforming growth factor-β superfamily of receptors. Cytokine Growth Factor Rev. 15, 1-11
26. Wu, M.Y. and Hill, C.S. (2009) Tgf-β superfamily signaling in embryonic development and homeostasis. Dev. Cell 16, 329-343
27. Pardali, E., Goumans, M.J. and ten Dijke, P. (2010) Signaling by members of the TGF-β family in vascular morphogenesis and disease. Trends Cell Biol. 20, 556-567
28. Itoh, S. and ten Dijke, P. (2007) Negative regulation of TGF-β receptor/Smad signal transduction. Curr. Opin. Cell Biol. 19, 176-184 (Pubitemid 46386411)
29. Goumans, M.J., Valdimarsdottir, G., Itoh, S., Rosendahl, A., Sideras, P. and ten Dijke, P. (2002) Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J. 21, 1743-1753 (Pubitemid 34614630)
30. Goumans, M.J., Valdimarsdottir, G., Itoh, S., Lebrin, F., Larsson, J., Mummery, C., Karlsson, S. and ten Dijke, P. (2003) Activin receptor-like kinase (ALK) 1 is an antagonistic mediator of lateral TGFβ/ALK5 signaling. Mol. Cell 12, 817-828 (Pubitemid 37352776)
31. Lebrin, F., Goumans, M.J., Jonker, L., Carvalho, R.L.C., Valdimarsdottir, G., Thorikay, M., Mummery, C.L., Arthur, H.M. and ten Dijke, P. (2004) Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduction. EMBO J. 23, 4018-4028 (Pubitemid 39472423)
32. David, L., Mallet, C., Mazerbourg, S., Feige, J.J. and Bailly, S. (2007) Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109, 1953-1961 (Pubitemid 46348192)
33. Scharpfenecker, M., van Dinther, M., Liu, Z., van Bezooijen, R.L., Zhao, Q., Pukac, L., Lowik, C.W. and ten Dijke, P. (2007) BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J. Cell Sci. 120, 964-972 (Pubitemid 46638511)
34. Lamouille, S., Mallet, C., Feige, J.J. and Bailly, S. (2002) Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 100, 4495-4501 (Pubitemid 35429690)
35. Cunha, S.I., Pardali, E., Thorikay, M., Anderberg, C., Hawinkels, L., Goumans, M.J., Seehra, J., Heldin, C.H., ten Dijke, P. and Pietras, K. (2010) Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis. J. Exp. Med. 207, 85-100
36. Upton, P.D., Davies, R.J., Trembath, R.C. and Morrell, N.W. (2009) Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells. J. Biol. Chem. 284, 15794-15804
37. Lebrin, F., Deckers, M., Bertolino, P. and ten Dijke, P. (2005) TGF-β receptor function in the endothelium. Cardiovasc. Res. 65, 599-608
38. Barbara, N.P., Wrana, J.L. and Letarte, M. (1999) Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-β superfamily. J. Biol. Chem. 274, 584-594
39. Castonguay, R., Werner, E.D., Matthews, R.G., Presman, E., Mulivor, A.W., Solban, N., Sako, D., Pearsall, R.S., Underwood, K.W., Seehra, J. et al. (2011) Soluble endoglin specifically binds BMP9/BMP10 via its orphan domain, inhibits blood vessel formation and suppresses tumor growth. J. Biol. Chem. 286, 30034-30046
40. Oh, S.P., Seki, T., Goss, K.A., Imamura, T., Yi, Y., Donahoe, P.K., Li, L., Miyazono, K., ten Dijke, P., Kim, S. and Li, E. (2000) Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 97, 2626-2631 (Pubitemid 30159221)
41. Arthur, H.M., Ure, J., Smith, A.J.H., Renforth, G., Wilson, D.I., Torsney, E., Charlton, R., Parums, D.V., Jowett, T., Marchuk, D.A. et al. (2000) Endoglin, an ancillary TGFβ receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev. Biol. 217, 42-53 (Pubitemid 30046798)
42. Jadrich, J.L., O'Connor, M.B. and Coucouvanis, E. (2006) The TGFβ activated kinase TAK1 regulates vascular development in vivo. Development 133, 1529-1541 (Pubitemid 43732966)
43. David, L., Mallet, C., Vailhe, B., Lamouille, S., Feige, J.J. and Bailly, S. (2007) Activin receptor-like kinase 1 inhibits human microvascular endothelial cell migration: potential roles for JNK and ERK. J. Cell. Physiol. 213, 484-489 (Pubitemid 47509730)
44. Roelen, B.A., van Rooijen, M.A. and Mummery, C.L. (1997) Expression of ALK-1, a type 1 serine/threonine kinase receptor, coincides with sites of vasculogenesis and angiogenesis in early mouse development. Dev. Dyn. 209, 418-430 (Pubitemid 27328468)
45. Jonker, L. and Arthur, H.M. (2002) Endoglin expression in early development is associated with vasculogenesis and angiogenesis. Mech. Dev. 110, 193-196
46. Niessen, K., Zhang, G., Ridgway, J.B., Chen, H. and Yan, M. (2010) ALK1 signaling regulates early postnatal lymphatic vessel development. Blood 115, 1654-1661
47. Mahmoud, M., Borthwick, G.M., Hislop, A.A. and Arthur, H.M. (2009) Endoglin and activin receptor-like-kinase 1 are co-expressed in the distal vessels of the lung: implications for two familial vascular dysplasias, HHT and PAH. Lab. Invest. 89, 15-25
48. Miller, D.W., Graulich, W., Kargas, B., Stahl, S., Ernst, M., Ramaswamy, A., Sadlacek, H.H., Muller, R. and Adamkiewicz, J. (1999) Elevated expression of endoglin, a component of the TGF-β-receptor complex, correlates with proliferation of tumour endothelial cells. Int. J. Cancer 81, 568-572 (Pubitemid 29203054)
49. Torsney, E., Charlton, R., Parums, D., Collis, M. and Arthur, H.M. (2002) Inducible expression of human endoglin during inflammation and wound healing in vivo. Inflamm. Res. 51, 464-470 (Pubitemid 35034452)
50. Seki, T., Yun, J. and Oh, S.P. (2003) Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ. Res. 93, 682-689 (Pubitemid 37222165)
51. van Laake, L.W., van den Driesche, S., Post, S., Feijen, A., Jansen, M.A., Driessens, M.H., Mager, J.J., Snijder, R.J., Westermann, C.J., Doevendans, P.A. et al. (2006) Endoglin has a crucial role in blood cell-mediated vascular repair. Circulation 114, 2288-2297 (Pubitemid 44789503)
52. Li, C., Issa, R., Kumar, P., Hampson, I.N., Lopez-Novoa, J.M., Bernabeu, C. and Kumar, S. (2003) CD105 prevents apoptosis in hypoxic endothelial cells. J. Cell Sci. 116, 2677-2685 (Pubitemid 36857221)
53. Lopez-Novoa, J.M. and Bernabeu, C. (2010) The physiological role of endoglin in the cardiovascular system. Am. J. Physiol. Heart Circ. Physiol. 299, H959-H974
54. Wiercinska, E., Wickert, L., Denecke, B., Said, H.M., Hamzavi, J., Gressner, A.M., Thorikay, M., ten Dijke, P., Mertens, P.R., Breitkopf, K. and Dooley, S. (2006) Id1 is a critical mediator in TGF-β-induced transdifferentiation of rat hepatic stellate cells. Hepatology 43, 1032-1041 (Pubitemid 43738969)
55. Finnson, K.W., Parker, W.L., ten Dijke, P., Thorikay, M. and Philip, A. (2008) ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes. J. Bone Miner. Res. 23, 896-906 (Pubitemid 351768808)
56. Bourdeau, A., Dumont, D.J. and Letarte, M. (1999) A murine model of hereditary hemorrhagic telangiectasia. J. Clin. Invest. 104, 1343-1351
57. Li, D.Y., Sorensen, L.K., Brooke, B.S., Urness, L.D., Davis, E.C., Taylor, D.G., Boak, B.B. and Wendel, D.P. (1999) Defective angiogenesis in mice lacking endoglin. Science 284, 1534-1537
58. Nomura-Kitabayashi, A., Anderson, G.A., Sleep, G., Mena, J., Karabegovic, A., Karamath, S., Letarte, M. and Puri, M.C. (2009) Endoglin is dispensable for angiogenesis, but required for endocardial cushion formation in the midgestation mouse embryo. Dev. Biol. 335, 66-77
59. Carvalho, R.L., Jonker, L., Goumans, M.J., Larsson, J., Bouwman, P., Karlsson, S., Dijke, P.T., Arthur, H.M. and Mummery, C.L. (2004) Defective paracrine signalling by TGFβ in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia. Development 131, 6237-6247 (Pubitemid 40123935)
60. Torsney, E., Charlton, R., Diamond, A.G., Burn, J., Soames, J.V. and Arthur, H.M. (2003) Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality. Circulation 107, 1653-1657 (Pubitemid 36397335)
61. Lebrin, F., Srun, S., Raymond, K., Martin, S., van den Brink, S., Freitas, C., Breant, C., Mathivet, T., Larrivee, B., Thomas, J.L. et al. (2010) Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat. Med. 16, 420-428
62. Park, S.O., Wankhede, M., Lee, Y.J., Choi, E.J., Fliess, N., Choe, S.W., Oh, S.H., Walter, G., Raizada, M.K., Sorg, B.S. and Oh, S.P. (2009) Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. J. Clin. Invest. 119, 3487-3496
63. Walker, E.J., Su, H., Shen, F., Choi, E.J., Oh, S.P., Chen, G., Lawton, M.T., Kim, H., Chen, Y., Chen, W. and Young, W.L. (2011) Arteriovenous malformation in the adult mouse brain resembling the human disease. Ann. Neurol. 69, 954-962
64. Corti, P., Young, S., Chen, C.Y., Patrick, M.J., Rochon, E.R., Pekkan, K. and Roman, B.L. (2011) Interaction between alk1 and blood flow in the development of arteriovenous malformations. Development 138, 1573-1582
65. Mahmoud, M., Allinson, K.R., Zhai, Z., Oakenfull, R., Ghandi, P., Adams, R.H., Fruttiger, M. and Arthur, H.M. (2010) Pathogenesis of arteriovenous malformations in the absence of endoglin. Circ. Res. 106, 1425-1433
66. Jerkic, M., Rodriguez-Barbero, A., Prieto, M., Toporsian, M., Pericacho, M., Rivas-Elena, J.V., Obreo, J., Wang, A., Perez-Barriocanal, F., Arevalo, M. et al. (2006) Reduced angiogenic responses in adult endoglin heterozygous mice. Cardiovasc. Res. 69, 845-854 (Pubitemid 43227983)
67. Seon, B.K., Haba, A., Matsuno, F., Takahashi, N., Tsujie, M., She, X., Harada, N., Uneda, S., Tsujie, T., Toi, H. et al. (2011) Endoglin-targeted cancer therapy. Curr. Drug Delivery 8, 135-143
68. Ikemoto, T., Hojo, Y., Kondo, H., Takahashi, N., Hirose, M., Nishimura, Y., Katsuki, T., Shimada, K. and Kario, K. (2011) Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases. Heart Vessels, doi:10.1007/s00380-011-0163-z
69. Wooten, E.C., Iyer, L.K., Montefusco, M.C., Hedgepeth, A.K., Payne, D.D., Kapur, N.K., Housman, D.E., Mendelsohn, M.E. and Huggins, G.S. (2010) Application of gene network analysis techniques identifies AXIN1/PDIA2 and endoglin haplotypes associated with bicuspid aortic valve. PloS ONE 5, e8830